Routine filing of dematerialisation certificate for Jul to Sep 2026 quarter

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+14.6%Reaction day

₹36.20

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.8%+13.8% vs market

Pharmaceuticals peers, median of 167sector-0.1%+14.8% vs sector

On the reaction day the stock moved 13.8 pts more than Nifty Microcap 250 and 14.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+14.6+0.8+13.8-0.1+14.8

Next day

+6.9+1.0+5.9-0.1+7.0

+12.2+1.7+10.5-0.3+12.5

+5.3+0.1+5.2-1.0+6.2

+3.6+0.8+2.8-0.8+4.4

-3.8-0.9-2.9-2.2-1.6

+2.0-4.5+6.5-4.7+6.7

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The company has submitted a routine compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 September 2026. Bigshare Services, the Registrar and Share Transfer Agent, confirmed that all share dematerialisation requests received during 1 July to 30 September 2026 were processed on time, physical certificates were cancelled, and depository names were updated in the register of members within the 15-day SEBI requirement.

Likely market impact

No material impact on shareholders or stock price. This is a standard quarterly procedural filing required by SEBI for all listed companies.